An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.
Trials. 2021 Jul 31;22(1):508. doi: 10.1186/s13063-021-05404-4.
Trials. 2021.
PMID: 34332638
Free PMC article.
Clinical Trial.